Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - valaciclovir as hydrochloride - טבליות מצופות פילם - valaciclovir as hydrochloride 500 mg - valaciclovir - valaciclovir - valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir in immunocompromised patients has not been established. valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). prophylaxis of cytomegalovirus infection and disease, following organ transplantation. for the treatment of cold sores (herpes labialis).

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - fosamprenavir as fosamprenavir calcium 700 mg - tablets - fosamprenavir - lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults. the following points should be considered when initiating therapy with lexiva/ritonavir in protease inhibitor - experienced patients: - the protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - once - daily administration of lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - abacavir as sulfate 300 mg; lamivudine 150 mg - tablets - zidovudine - for the treatment of human immunodeficiency virus (hiv) infected adults.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 150 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine; zidovudine - טבליות מצופות פילם - lamivudine 150 mg; zidovudine 300 mg - lamivudine - lamivudine - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine 100 mg - tablets - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - טבליה - lamivudine 100 mg - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - תמיסה (פומי) - lamivudine 5 mg/ml - lamivudine - lamivudine - zeffix is indicated for the treatment of chronic hepatitis b associated with the evidence of hepatitis b viral (hbv) replication and active liver inflammation in adults and also in children and adolescents aged 2 to 17 years old.

Ізраїль - іврит - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 300 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.